A comprehensive analysis of clinical trials in pancreatic cancer: what is coming down the pike?

por Katayama, Erryk S., Hue, Jonathan J., Bajor, David L., Ocuin, Lee M., Ammori, John B., Hardacre, Jeffrey M., Winter, Jordan M.
Publicado 2020

The Impact of COVID-19 on Time-to-treatment in Pancreatic Adenocarcinoma: A Single Institutional Experience

por Sugumar, Kavin, Cao, Lifen, Hue, Jonathan J., Rothermel, Luke, Ocuin, Lee M., Ammori, John B., Hardacre, Jeffrey M., Winter, Jordan M.
Publicado 2021

The importance of time‐to‐adjuvant treatment on survival with pancreatic cancer: A systematic review and meta‐analysis

por Sugumar, Kavin, Hue, Jonathan J., De La Serna, Solanus, Rothermel, Luke D., Ocuin, Lee M., Hardacre, Jeffrey M., Ammori, John B., Winter, Jordan M.
Publicado 2021

Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic Cancer

por Hue, Jonathan J., Bingmer, Katherine, Sugumar, Kavin, Markt, Sarah C., Rothermel, Luke D., Hardacre, Jeffrey M., Ammori, John B., Winter, Jordan M., Ocuin, Lee M.
Publicado 2021

Trends in Melanoma Phase 3 Clinical Trials since 2010: Is there Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms?

por Kakish, Hanna H., Ahmed, Fasih Ali, Elshami, Mohamedraed, Loftus, Alexander W., Hoehn, Richard S., Ammori, John B., Ocuin, Lee M., Winter, Jordan M., Bordeaux, Jeremy S., Mangla, Ankit, Rothermel, Luke D.
Publicado 2022

The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs)

por Mohamed, Amr, Asa, Sylvia L., McCormick, Thomas, Al-Shakhshir, Hilmi, Dasari, Arvind, Mauricio, Retuerto, Salem, Iman, Ocuin, Lee M., Bajor, David, Lee, Richard T., Selfridge, J. Eva, Kardan, Arash, Lee, Zhenghong, Avril, Norbert, Kopp, Shelby, Winter, Jordan M., Hardacre, Jeffrey M., Ammori, John B., Ghannoum, Mahmoud A.
Publicado 2022